| ||
| Pfizer files for EU approval of axitinib in advanced kidney cancer ... Pfizer's targeted cancer drug portfolio will be worth nearly $3 billion by 2015, driven mostly by sales of Sutent (sunitinib maleate), figitumumab (being investigated for the treatment of non-small-cell lung, prostate, ... thepharmaletter.com - http://www.thepharmaletter.com/ |
| ||
| Plainsboro PRODUCT MANAGER, NON-SMALL CELL LUNG CAN JOB - NJ, 08536 The Erbitux team is preparing to launch a new indication in Non-Small Cell Lung Cancer (NSCLC) . As a member of the Erbitux NSCLC team, the candidate will ... jobs.bms.com/job/Plainsboro-PRODUCT.../1284822/ |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment